2010
DOI: 10.1111/j.1464-410x.2010.09165.x
|View full text |Cite
|
Sign up to set email alerts
|

Why do men opt out of prostate‐cancer screening? Attitudes and perception among participants and non‐participants of a screening trial

Abstract: Study Type – Decision analysis (patient preference)
Level of Evidence 4 OBJECTIVE To evaluate attitudes to prostate cancer screening with prostate‐specific antigen (PSA) of men who complied with offered screening and those who declined it within the Finnish randomized population‐based screening trial, and to compare general health‐related quality of life (HRQL) between participants and non‐participants. SUBJECTS AND METHODS Self‐administered questionnaires were sent to 500 men randomized into the screening arm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
1

Year Published

2012
2012
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 21 publications
0
5
0
1
Order By: Relevance
“…Screening identified 19 relevant studies (see Figure 2 and Table 1). Of the 19 included studies, 9 measured rumination (emotional rumination: Aldridge-Gerry et al, 2011; rumination: Ciesla et al, 2011; Dvorak et al, 2011; Willem et al, 2011; Cropley et al, 2012; Adrian et al, 2014; Frone, 2015; Willem et al, 2014; angry rumination: Ciesla et al, 2011; anxious rumination: Harwell et al, 2011), 9 studies measured health-related worry (Dijkstra and Brosschot, 2003; Li et al, 2009; Malmi et al, 2010; Rutten et al, 2011; Ferrer et al, 2013a,b; Swayampakala et al, 2013; Yong et al, 2014; Bernat et al, 2015), and 2 studies measured general worry (Shoal et al, 2005; Ciesla et al, 2011). In addition, four studies measured reflection (Willem et al, 2011, 2014; Cropley et al, 2012; Adrian et al, 2014).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Screening identified 19 relevant studies (see Figure 2 and Table 1). Of the 19 included studies, 9 measured rumination (emotional rumination: Aldridge-Gerry et al, 2011; rumination: Ciesla et al, 2011; Dvorak et al, 2011; Willem et al, 2011; Cropley et al, 2012; Adrian et al, 2014; Frone, 2015; Willem et al, 2014; angry rumination: Ciesla et al, 2011; anxious rumination: Harwell et al, 2011), 9 studies measured health-related worry (Dijkstra and Brosschot, 2003; Li et al, 2009; Malmi et al, 2010; Rutten et al, 2011; Ferrer et al, 2013a,b; Swayampakala et al, 2013; Yong et al, 2014; Bernat et al, 2015), and 2 studies measured general worry (Shoal et al, 2005; Ciesla et al, 2011). In addition, four studies measured reflection (Willem et al, 2011, 2014; Cropley et al, 2012; Adrian et al, 2014).…”
Section: Resultsmentioning
confidence: 99%
“…Health behaviors investigated were alcohol consumption (Shoal et al, 2005; Aldridge-Gerry et al, 2011; Ciesla et al, 2011; Harwell et al, 2011; Willem et al, 2011, 2014; Adrian et al, 2014; Frone, 2015), marijuana use (Shoal et al, 2005; Willem et al, 2011; Adrian et al, 2014; Willem et al, 2014), smoking behavior and cessation (Dijkstra and Brosschot, 2003; Dvorak et al, 2011; Rutten et al, 2011; Swayampakala et al, 2013; Yong et al, 2014), eating behavior (Cropley et al, 2012; Ferrer et al, 2013a,b), cancer screening uptake (Malmi et al, 2010) and levels of physical activity (Li et al, 2009; Ferrer et al, 2013b; Bernat et al, 2015). See Table 1 for a more detailed overview of the included studies.…”
Section: Resultsmentioning
confidence: 99%
“…Nevertheless, the present findings concur with those of other studies that have used quality of life questionnaires. Neither in The Rotterdam trial [ 22 ] nor in the ProtecT trial [ 23 ] and nor in the Finnish arm of the European randomized screening trial (ERSPC) [ 24 ] was health-related quality of life associated with the decision to attend PSA testing.…”
Section: Discussionmentioning
confidence: 99%
“…For the outcome of receiving Pap test, participants were classified by receiving Pap test <3 years versus receiving it ≥3 years (excluding never). In other words, we were investigating factors related to ‘on-time screening’ compared to ‘delayed screening.’ We excluded those who never received mammography or Pap test screening since the mechanisms and factors influencing those never receiving screening differ than those having received screening [39,40]. Women diagnosed with any form of cancer were excluded from the analyses and only women who reported not having a hysterectomy were included in the Pap test analyses [7].…”
Section: Methodsmentioning
confidence: 99%